| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/08/2003 | EP1272485A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272474A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1077945B1 Isoquinolines as urokinase inhibitors |
| 01/08/2003 | EP0892795B1 Piperidinylpyramidine derivatives |
| 01/08/2003 | CN1390214A New phenylpiperazines |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098260C 2,4-diaminopyrimidine derivatives |
| 01/08/2003 | CN1098259C Novel carboxy substituted cyclic carboxamide derivatives |
| 01/08/2003 | CN1098254C Sulfonamides |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |
| 01/07/2003 | US6503938 Treatment of estrogen related disease or tumor, including prostatic hyperplasia, breast cancer, endometrial carcinoma, anovulatory infertility, melanoma or osteoporosis |
| 01/07/2003 | US6503937 Coloring agents for high molecular weight materials such as polymers |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503926 Nitrogen heterocycle compounds |
| 01/07/2003 | US6503925 Treating anxiety, anesthesia, and epilepsy |
| 01/07/2003 | US6503917 Post-menopause, atherosclerosis, osteoporosis, and Alzheimer*s disease treatment |
| 01/07/2003 | US6503901 Amino lactam sulfonamides as inhibitors of Aβ protein production |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/05/2003 | CA2392189A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000679A2 Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 01/03/2003 | WO2003000676A1 1,2,4-trioxolane antimalarials |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000665A1 Antibacterial uracil derivatives |
| 01/03/2003 | WO2003000664A1 Uracil derivatives and the use thereof for treating bacterial diseases |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000261A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | WO2003000255A1 Novel nitrofuran-containing heterocyclic compounds and uses thereof |
| 01/03/2003 | WO2003000251A1 Novel idolinones and uses thereof |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2001083800A8 Heterologous production of polyketides |
| 01/03/2003 | CA2455292A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2454538A1 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same |
| 01/03/2003 | CA2451664A1 Use of bicyclo compounds for treating alzheimer's disease |
| 01/03/2003 | CA2451354A1 Herbicidal substituted pyridines, their preparation, and their use as herbicides and plant growth regulators |
| 01/03/2003 | CA2451249A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | CA2450491A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2450174A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | CA2449844A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/02/2003 | US20030004358 Treatment of peptic ulcers |
| 01/02/2003 | US20030004352 Contacting a racemic mixture of the piperidine carbinol in solution with ditoluoyltartaric acid, crystallising the salt and neutralizing |
| 01/02/2003 | US20030004351 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 01/02/2003 | US20030004340 Skin disorders; gastrointestinal disorders |
| 01/02/2003 | US20030004202 Endothelin receptor antagonists |
| 01/02/2003 | US20030004195 Reducing pressure in eye |
| 01/02/2003 | US20030004194 Method for treating fibrotic diseases or other indications VI |
| 01/02/2003 | US20030004189 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| 01/02/2003 | US20030004188 Crystal structure; desolventization |
| 01/02/2003 | US20030004187 Method for preventing dyskinesias |
| 01/02/2003 | US20030004186 Anticoagulants; cardiovascular disorders; central nervous system disorders |
| 01/02/2003 | US20030004166 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | US20030000129 Transition-metal-catalyzed process for the preparation of sterically hindered N-substituted alkoxy amines |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1270559A1 Novel imidazole derivatives with anti-inflammatory activity |
| 01/02/2003 | EP1268484A1 Condensed imidazoles as histamine h3 receptor ligands |
| 01/02/2003 | EP1268483A1 Condensed imidazoles as histamine h3 receptor ligands |
| 01/02/2003 | EP1268471A1 N-heterocyclic derivatives as nos inhibitors |
| 01/02/2003 | EP1268470A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 01/02/2003 | EP1268466A1 Decahydro-isoquinolines |
| 01/02/2003 | EP1268465A1 Triarylimidazole derivatives as cytokine inhibitors |
| 01/02/2003 | EP1268463A2 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268445A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 01/02/2003 | EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/02/2003 | EP1268436A1 Novel diaminopyrazole derivatives and dyes containing said compounds |
| 01/02/2003 | EP1268434A1 Cyclic lactams as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268428A2 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 01/02/2003 | EP1268422A1 Indoles for treating diseases that can be treated using thyroid hormones |
| 01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268306A1 Inverted aerosol dispenser |
| 01/02/2003 | EP1219614A9 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction |
| 01/02/2003 | EP1115716B1 2-phenylpyran-4-one derivatives |
| 01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |